RE: RNS we have a buyer9 Apr 2024 18:17
Just because there are 'many more crap companies' (than this one), does not make this a quality company, worthy of investment, either.
As witnessed by at least two of the major shareholders, who decided to allow their positions to be diluted, rather than participate in this raise.
Pathetic levels of inside buying, with dilution that was so bad for existing holders, you struggle to see a bull case, even if you really want to.
Entirely justified lack of trust/faith in the BOD, based on their track record...since the year dot really.
Lack of Stal update continues. After the Juv abortion, faith in the entire pipeline hanging by a thread, IMO.
Absolutely nothing on the old cancer trial stuff either for ages, which was what first interested me all those years ago. If it is dead, just tell us, rather than the corporate waffle about progressing talks, which is/was clearly rubbish.
And yes, from a technical POV, so many far better technical trade prospects right now, so it fails from both an investment and a technical chart perspective too, IMO.
None of which means it might not have a (short) spike or two at some point before it goes pop once and for all (not 100% certain of course, yet IMO virtually so)...but again, better rainbows to chase than this one for a pure punt too, IMO.
But no harm in having different opinions :) GLA.